187

 

1.      Al‐Muhaya MA, Najjar AH, Jelly AA, et al. Palliative emergency stenting of the vertical vein in obstructive supracardiac pulmonary venous drainage prior to surgical repair. J Saudi Heart Assoc. 2019;31:64-8. Doi: 10.1016/j.jsha.2018.12.001

2.      Assimes TL, Malcolm I. Torsades de pointes with sotalol overdose treated successfully with lidocaine. Can J Cardiol. 1998;14(5):753-6.

3.      Auslenderu M. Pathophysiology of pediatric heart failure. Progress in Pediatric Cardiology 2000;175-84. Doi: 10.1016/S1058-9813(00)00048-5.

4.      Azak E, Ünsal H, Kibar AE, et all. Çocuklalrda Konjestif Kalp Yetersizliği. Türkiye Çocuk Hastalıkları Dergisi.2016;224-31. Doi: 10.12956/tjpd.2016.206

5.      Bakiler AR, Ayvaz Aydoğdu S, Erişen S, Yenigün A, Atay Y. A case of mitral papillary muscle rupture due to blunt chest trauma. Turk J Pediatr 2011; 53: 97-9.

6.      Bano S, Akhtar S, Khan U. Pediatric congenital heart diseases: Patterns of presentation to the emergency department of a tertiary care hospital. Pak J Med Sci. 2020;36(3):333-7. Doi: 10.12669/pjms.36.3.1592.

7.      Bardai A, Berdowski J, Van Der Werf C, et al. Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children a comprehensive, prospective, population-based study in the Netherlands. JACC. 2011;57:1822-8. Doi: 10.1016/j.jacc.2010.11.054.

8.      Bruschi G, Agati S, Iorio F, Vitali E. Papillary muscle rupture and pericardial injuries after blunt chest trauma. Eur J Cardiothorac Surg 2001; 20: 200-2. Doi: 10.1016/s1010-7940(01)00727-8.

9.      Cinteza E, Carminati M. Balloon atrial septostomy–almost half a century after. Maedica. 2013; 8(3): 280-4.

10.  Demir F, Bilici M. Pediyatrik aritmiler. Dicle Tıp Dergisi. 2015;42(1):128-35. Doi:10.5798/diclemedj.0921.2015.01.0547

11.  Dilli D, Akduman H, Çitli R, et al. Management of Ductus-Dependent Systemic Circulatiory Lesions in the Neonatal Period: A Ten-Year Experience. Arq Bras Cardiol.2025;122 (3): 7-31. Doi: 10.36660/abc.20230731.

12.  Engdahl J, Axelsson A, Bang A, et al. The epidemiology of cardiac arrest in children and young adults. Resuscitation. 2003;58:131-8. Doi: 10.1016/s0300-9572(03)00108-4.

13.  Fikar ÇR, Fikar R. Aortic dissection in childhood and adolescence: an analysis of occurrences over a 10-year interval in New York State. Clin Cardiol. 2009;32(6):23-6. Doi: 10.1002/clc.20383.

14.  Fikar ÇR, Koç S. Etiologic factors of acute aortic dissection in children and young adults. Clin Pediatr. 2000;39(2):71-80. Doi: 10.1177/000992280003900201.

15.  Han B, Nair ÇK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest. 2002;122(1):311-28. Doi: 10.1378/chest.122.1.311.

16.  Hatzaras I, Tranquilli M, Coady M, et al. Weight lifting and aortic dissection: more evidence for a connection. Cardiology. 2007;107(2):103-6. Doi: 10.1159/000094530.

17.  Hickey PR, Hansen DD. Pulmonary hypertension in infants: Postoperative management. IN: Yacoub M, ed. Annual of Cardiac Surgery, London: Current Science 1989:16-22.

18.  Jefferies JL, Price JF, Denfield SW, Chang AC, Dreyer WJ, McMahon CJ, et al. Safety and efficacy of nesiritide in pediatric heart failure. J Card Fail 2007;13:541-8. Doi: 10.1016/j.cardfail.2007.04.005.

19.  Kashyap S. Approach and management of cyanotic newborn: Guidance for primary caretakers. Gujarat Medical Journal 2010;65:94-6.

20.  Kline JA, Raymond RM, Schroeder Jd, et al. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol.1997;145(2):357-62. Doi: 10.1006/taap.1997.8195.

21.  Lüscher TF, Cosentino F. The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal. Drugs. 1998;55(4):509-17. Doi 10.2165/00003495-199855040-00003.

22.  Magdalan J. New treatment methods in verapamil poisoning: experimental studies. Pol J Pharmacol. 2003:55(3):425-32.

23.  Marfil-Godoy L, Marti-Aguasca G, Ferrer-Menduina Q, et al. Duktal stenting in congenital heart disease with duct dependent pulmonary blood flow. Rev Esp Cardiol. 2020;73(10):859-61. Doi: 10.1016/j.rec.2020.03.014. 

24.  Menahem S, Sehgal A, Meagher S. Early detection of significant congenital heart disease: The contribution of fetal cardiac ultrasound and newborn pulse oximetry screening. J Pediatr. 2021;57(3):323-7. Doi: 10.1111/jpc.15355.

25.  Momma K. Lipo‐PGE1 treatment of the neonate with critical congenital heart disease and ductus‐arteriosus dependent circulation. Advanced Drug Delivery Reviews 1996;20(2‐3):177‐80. Doi: 10.1016/0169-409X(95)00121-M

26.  Moulik PK, Nethaji C, Khaleeli AA. Misleading electrocardiographic results in patients with hyperkalaemia and diabetic ketoacidosis. BMJ 2002; 325:1346–7. Doi: 10.1136/bmj.325.7376.1346.

27.  Namachivayam P, Crossland DS, Butt WW, Shekerdemian LS. Early experience with levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med 2006;7:445-8. Doi: 10.1097/01.PCC.0000235251.14491.75.

28.  Park MK. Park’s Pediatric Cardiology for Practitioners. Philadelphia, Elsevier Saunders, 2014.

29.  Park MK. Pediatric Cardiology for Practitioners. Fifth edition. 239 pages.

30.  Price JF, Thomas AK, Grenier M, Eidem BW, O’Brian Smith E, Denfield SW, et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 2006;114:1063-9. Doi: 10.1161/CIRCULATIONAHA.105.608869.

31.  Reffelmann T, Kloner RA. Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation. 2003;108(2):239-444. Doi:10.1161/01.cir.0000081166.87607.e2

32.  Reith DM, Dawson AH, Epid D, et al. Relative toxicity of beta blockers in overdose. J Toxicol Clin. 1996;34(3):273-8. Doi: 10.3109/15563659609013789.

33.  Rose M, Strange G, King I, et al. Congenital heart disease associated pulmonary arterial hypertension: preliminary results from a novel registry. Intern Med J. 2011;1445-5994. Doi: 10.1111/j.1445-5994.2011.02708.x

34.  Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatric Cardiolog 1992;13:72-5. Doi: 10.1007/BF00798207.

35.  Schulze Neick I, Hartenstein P, Li J, et al. İntravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation. 2003;108:167-73. Doi: 10.1161/01.cir.0000087384.76615.60

36.  Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, et al. Carvedilol for children and adolescents with heart failure: A randomized controlled trial. JAMA 2007;298:1171-9. Doi: 10.1001/jama.298.10.1171.

37.  Shaddy RE, Teitel DF, Brett C. Short term hemodynamic effects of captopril in children with congestive or restrictive cardiomyopathy. Circulation 1991;83:523-7. Doi: 10.1001/archpedi.1988.02150010110036.

38.  Shepherd G. Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers. Am J Health-Syst Pharm.2006;63(19):1828-35. Doi: 10.2146/ajhp060041.

39.  Simmers TA, Meijburg HW, de la Riviere AB. Traumatic papillary muscle rupture. Ann Thorac Surg 2001; 72: 257-9. Doi: 10.1016/s0003-4975(00)02498-x.

40.  Talner NS. Heart Failure. Emmanuilides GC, Allen DH, Gutgesell HP, Riemenschneider TA (eds). Moss and Adams’ Heart Disease in Infants, Children, and Adolescents. Philadelphia: Lippincott Williams &Wilkin, 2008:1495-520.

41.  The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302. Doi: 10.1056/NEJM199108013250501.

42.  Triggle DJ, Janis RA. Recent development in calcium channel antagonists. Magnesium. 1989;8(5-6):213-22.

43.  Van Mieghem CSabbe MKnockaert D.The clinical value of the ECG in noncardiac conditions. Chest. 2004 Apr;125(4):1561-76. Doi: 10.1378/chest.125.4.1561.

44.  Weeda JA, Straver BB, Hahurij ND, et al. Balloon atrial septostomy for transposition of the great arteries: Safety and experience with the Z-5 balloon catheter. Catheter Cardiovasc Interv. 2024;103:308-16. Doi: 10.1002/ccd.30932

45.  Wessel DL, Adatia I, Giglia TM, et al. Use of the inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 1993;88:2128-3238. Doi: 10.1161/01.cir.88.5.2128

46.  Zhu X, Yu J, Ma L, et al. Anatomic variations and corresponding surgical techniques of total anomalous pulmonary venous connection. Natl Med J China. 2011;91:2099-102.

47.  Zile MR, Gaasch WH, Carroll JD, Feldman MD, Aurigemma GP, Schaer GL, et al. Heart failure with abnormal ejection fraction. Is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure. Circulation 2001;104:779-82. Doi: 10.1161/hc3201.094226.

ideasoft e-ticaret paketleri ile hazırlandı.